New Zealand markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
301.18+2.28 (+0.76%)
At close: 04:04PM EDT
301.18 0.00 (0.00%)
After hours: 05:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 21.37B
Enterprise value 21.04B
Trailing P/E 32.17
Forward P/E 31.45
PEG ratio (5-yr expected) 4.05
Price/sales (ttm)7.65
Price/book (mrq)9.19
Enterprise value/revenue 7.30
Enterprise value/EBITDA 23.55

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-16.99%
S&P500 52-week change 3-11.33%
52-week high 3475.35
52-week low 3275.89
50-day moving average 3315.86
200-day moving average 3390.55

Share statistics

Avg vol (3-month) 3449.11k
Avg vol (10-day) 3481.42k
Shares outstanding 574.08M
Implied shares outstanding 6N/A
Float 873.64M
% held by insiders 10.62%
% held by institutions 197.86%
Shares short (30 May 2022) 4728.11k
Short ratio (30 May 2022) 41.5
Short % of float (30 May 2022) 41.28%
Short % of shares outstanding (30 May 2022) 40.98%
Shares short (prior month 28 Apr 2022) 4983.38k

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.25%
Trailing annual dividend rate 30.70
Trailing annual dividend yield 30.23%
5-year average dividend yield 40.38
Payout ratio 47.80%
Dividend date 302 Aug 2022
Ex-dividend date 418 Jul 2022
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 23.76%
Operating margin (ttm)26.83%

Management effectiveness

Return on assets (ttm)16.01%
Return on equity (ttm)32.94%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)38.66
Quarterly revenue growth (yoy)7.40%
Gross profit (ttm)1.18B
EBITDA 895.6M
Net income avi to common (ttm)684.4M
Diluted EPS (ttm)8.97
Quarterly earnings growth (yoy)14.90%

Balance sheet

Total cash (mrq)667.7M
Total cash per share (mrq)9.01
Total debt (mrq)331.2M
Total debt/equity (mrq)14.24
Current ratio (mrq)2.89
Book value per share (mrq)31.39

Cash flow statement

Operating cash flow (ttm)646.5M
Levered free cash flow (ttm)253.29M